Cholera Vaccine Investment Strategy in Bangladesh
Condition(s):CholeraLast Updated:December 20, 2019Completed
Hide Studies Not Open or Pending
Condition(s):CholeraLast Updated:December 20, 2019Completed
Condition(s):Anal Intraepithelial Neoplasia; Anal Cancer; Human Papilloma VirusLast Updated:June 13, 2022Not yet recruiting
Condition(s):Human Papillomavirus VaccinationLast Updated:February 25, 2022Completed
Condition(s):MalariaLast Updated:August 3, 2022Recruiting
Condition(s):High Risk for Serious Influenza; High Risk for PneumoniaLast Updated:September 26, 2006Unknown status
Condition(s):Human Papillomavirus VaccinesLast Updated:January 30, 2024Terminated
Condition(s):Pneumococcal CarriageLast Updated:September 22, 2023Active, not recruiting
Condition(s):Pregnant Women; COVID 19 Vaccine; Vaccination HesitancyLast Updated:February 16, 2023Completed
Condition(s):Vaccination PromotionLast Updated:April 27, 2021Completed
Condition(s):Diphtheria; Acellular Pertussis; Tetanus; Aspergillosis, Allergic Bronchopulmonary; Diphtheria-Tetanus-acellular Pertussis VaccinesLast Updated:February 22, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.